This research demonstrates in ovo sexing and genotyping in chicken embryos, improving animal research ethics by addressing nociception.
Early sex determination and genotyping of chicken embryos is crucial for ethical and resource-efficient animal research. We developed a reproducible workflow using whole genome amplification combined (WGA) with Kompetitive Allele Specific PCR (KASP) and standard endpoint PCR to perform in ovo sexing and genotyping from embryonic day 4 (ED4) to ED10. Across four study phases involving various chicken lines—including a genetically modified line, Araucana crossbreeds, and commercial layers (total n = 819)—we evaluated methodological feasibility, accuracy, and hatchability. Both PCR methods demonstrated high success rates in yielding results (70–100%) and high identification accuracy (92–100%) throughout all developmental stages tested. While the overall efficiency improved with embryonic age, ED7 was identified as the optimal time point to balance reliable sampling with high hatchability. We conclude that this laboratory-scale, PCR-based protocol provides an accessible and precise method for research laboratories to identify sex and genotype simultaneously. This approach directly supports the 3R principles by preventing the hatching of surplus animals before the assumed onset of nociception (ED13).
No takes yet. Share an insight, caveat, or question.
Dierks et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: